As of December 2024, Aurinia Pharmaceuticals has a market cap of $1.38B. This makes Aurinia Pharmaceuticals the world's 1980th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $815.73M | -36.65% |
2023 | $1.29B | 108.10% |
2022 | $618.78M | -81.11% |
2021 | $3.28B | 65.37% |
2020 | $1.98B | -31.74% |
2019 | $2.90B | 197.07% |
2018 | $976.87M | 50.55% |
2017 | $648.86M | 115.71% |
2016 | $300.80M | -14.98% |
2015 | $353.79M | -32.14% |
2014 | $521.38M | - |